Hefei Limin Pharmaceutical Co., Ltd.
-
Founded in:
1998-10-22 -
Country:
China -
Address:
No. 41, Yulan Avenue, Taohua Town, Feixi County, Hefei City, Anhui Province -
Tax NO.:
91340123149193656T -
Registered Funds:
50 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| N-ethyl-N-(4-pyridylmethyl)-alpha;-(hydroxymethyl)-phenylacetamide |
This product is an anticholinergic drug that can block the excitation of the iris sphincter and ciliary muscle caused by acetylcholine. Its 0.5% solution can cause mydriasis; 1% solution can cause ciliary muscle paralysis and mydriasis.
More
This product is an anticholinergic drug that can block the excitation of the iris sphincter and ciliary muscle caused by acetylcholine. Its 0.5% solution can cause mydriasis; 1% solution can cause ciliary muscle paralysis and mydriasis. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Rifampicin |
Rifampicin is a semi-synthetic broad-spectrum bactericidal agent. This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment treatment of tuberculosis. It is also suitable for asymptomatic meningococcal carriers to eliminate Neisseria meningitidis in the nasopharynx (this product is not suitable for the treatment of meningococcal infection). Rifampicin can also be considered for preventing infection in contacts of influenza bacilli; combined with other drugs, it is used to treat leprosy and atypical mycobacterium infections.
More
Rifampicin is a semi-synthetic broad-spectrum bactericidal agent. This product is used in combination with other anti-tuberculosis drugs for the initial and retreatment treatment of tuberculosis. It is also suitable for asymptomatic meningococcal carriers to eliminate Neisseria meningitidis in the nasopharynx (this product is not suitable for the treatment of meningococcal infection). Rifampicin can also be considered for preventing infection in contacts of influenza bacilli; combined with other drugs, it is used to treat leprosy and atypical mycobacterium infections. |
0.15g | 13292-46-1 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| MonoclofenamicAcid |
This product is a non-steroidal anti-inflammatory drug and a derivative of anthranilic acid. It can inhibit cyclooxygenase, reduce the synthesis of prostaglandins, and has anti-inflammatory, analgesic and antipyretic effects.
More
This product is a non-steroidal anti-inflammatory drug and a derivative of anthranilic acid. It can inhibit cyclooxygenase, reduce the synthesis of prostaglandins, and has anti-inflammatory, analgesic and antipyretic effects. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hawthorn (burnt) |
|
0 | ||
| Liu Shen Qu (fried) |
|
0 | ||
| Pinellia (processed) |
|
0 | ||
| Radish seeds (fried) |
|
0 | ||
| Malt (roasted) |
|
0 | ||
| Poria |
|
0 | ||
| Citri reticulatae pericarpium |
|
0 | ||
| Forsythiae Fructus |
|
0 | ||
| Sucrose |
|
57-50-1 | 73 | |
| Dextrin |
|
9004-53-9 | 49 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.
More
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect. |
126mg | 103-90-2 | 68 |
| Acetylsalicylic acid |
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.
More
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect. |
230mg | 50-78-2 | 35 |
| Caffeine |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
30mg | 0 |